ニキビ治療薬の世界市場レポート2024

ニキビ治療薬の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.5%の年間複合成長率（CAGR）で73億米ドルに成長すると予想されます。予測期間中に予想される成長は、景気拡大の加速、ヘルスケアの増大、新興国の大きな潜在力、10代人口の増加、座りがちなライフスタイルの蔓延に関連している可能性があります。予測期間中に予想される注目すべき動向には、狭スペクトル抗生物質への戦略的投資、ニキビ治療のための併用療法の製剤化、大麻製品、特に大麻油を含む製品への財政的コミットメント、新薬開発のためのパートナーシップ、ニキビ治療製品のマーケティングのためのソーシャルメディアプラットフォームの活用などが含まれます。

ニキビ治療薬市場は人々の可処分所得の上昇に大きく影響され、大きな原動力となっています。可処分所得の増加は通常、経済の改善を反映しており、その結果、賃金と給与が増加し、その結果、ヘルスケア支出が拡大します。米経済分析局によると、個人の可処分所得は2023年7月に73億米ドル急増しました。この可処分所得の増加は、フェイシャルケア製品への支出の拡大と相まって、今後も続くと予想され、それによって予測期間中の市場の成長を促進することになります。

ニキビの有病率の拡大は、予見可能な将来においてニキビ治療市場の成長を推進する主要な原動力となると予測されています。ニキビは、油分や死んだ皮膚細胞による毛穴の詰まりから生じる皮膚疾患であり、人々は治療法を求めるようになります。 ニキビ治療薬は、炎症を緩和し、油分の生成を減らし、毛穴の詰まりを防ぐことで機能し、最終的にニキビができやすい肌の外観を改善します。世界人口のほぼ90%が何らかの形のニキビに悩まされており、この症状は広範な課題を引き起こしています。米国だけでも、約1,200万人が重度のニキビに悩まされており、治療しないと皮膚に瘢痕が残る可能性があります。その結果、人口のかなりの部分がニキビの状態を管理するためにニキビケア薬や製品に投資しています。したがって、ニキビの有病率の増加は、ニキビ治療薬市場の成長を促進する実質的な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のニキビ治療薬市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 炎症性ニキビ治療薬
• 非炎症性ニキビ治療
• 世界のニキビ治療薬市場、治療クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• レチノイド
• 抗生物質
• サリチル酸
• 過酸化ベンゾイル
• 世界のニキビ治療薬市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院とクリニック
• 薬局・ドラッグストア
• 外来手術センター

第7章 地域および国の分析

• 世界のニキビ治療薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のニキビ治療薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ニキビ治療薬市場の競合情勢
• ニキビ治療薬市場の企業プロファイル
  • Johnson &Johnson
  • Galderma SA
  • Almirall SA
  • Bausch Health Companies Inc.
  • GlaxoSmithKline

第31章 その他の大手および革新的な企業

• Reckitt Benckiser Group
• Mayne Pharma Group Limited
• Allergan Plc.
• Cipher Pharmaceuticals
• Sol Gel Advanced Topical Therapy
• Pfizer Inc.
• Novartis AG
• Merck &Co. Inc.
• Amgen Inc.
• Abbott
• AstraZeneca
• Eli Lilly and Company
• Daiichi Sankyo Company Limited
• Sinopharm Group Co. Ltd
• Mylan NV

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Acne medications encompass pharmaceutical solutions designed to address issues related to acne scarring, blackheads, whiteheads, and more severe forms of the condition. These drugs operate by either targeting bacterial infections or reducing edema and oil production. Typically, a timeframe of four to eight weeks is required before prescription acne medications demonstrate efficacy. Complete resolution of acne may extend over several months or even years.

The primary categories of acne drugs include inflammatory and non-inflammatory variants. Inflammatory acne drugs are employed for the treatment of mild to moderate inflammatory acne. Key therapeutic classes comprise retinoids, antibiotics, salicylic acid, and benzoyl peroxide. These medications find application across various end-user segments, including hospitals, clinics, pharmacies, drug stores, and ambulatory surgical centers.

The acne drugs market research report is one of a series of new reports from The Business Research Company that provides acne drugs market statistics, including acne drugs industry global market size, regional shares, competitors with an acne drugs market share, detailed acne drugs market segments, market trends and opportunities, and any further data you may need to thrive in the acne drugs industry. This acne drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acne drugs market size has grown steadily in recent years. It will grow from $5.84 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth observed in the historical period can be ascribed to several factors, including the escalating prevalence of acne, a growing population, robust economic expansion, an upswing in pharmaceutical spending, increased disposable income, and a rise in healthcare expenditure.

The acne drugs market size is expected to see steady growth in the next few years. It will grow to $7.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be linked to accelerated economic expansion, heightened healthcare expenditure, the substantial potential of emerging economies, a rising teenage population, and the prevalence of sedentary lifestyles. Noteworthy trends expected in the forecast period involve strategic investments in narrow-spectrum antibiotics, the formulation of combination therapies for acne treatment, financial commitments in cannabis products, particularly those containing cannabis oil, partnerships for the development of novel drugs, and leveraging social media platforms for the marketing of acne treatment products.

The acne drug market is significantly influenced by the rise in people's disposable income, serving as a major driving force. The escalation in disposable income typically mirrors an improved economy, resulting in augmented wages and salaries, consequently amplifying healthcare spending. According to the Bureau of Economic Analysis, disposable personal income surged by $7.3 billion in July 2023. This upsurge in disposable income, coupled with amplified expenditure on facial care products, is anticipated to persist, thereby fueling market growth during the forecast period.

The escalating prevalence of acne is projected to be a key driver propelling the growth of the acne drug market in the foreseeable future. Acne, a skin condition arising from clogged pores due to oil and dead skin cells, prompts individuals to seek remedies. Acne drugs function by mitigating inflammation, reducing oil production, and preventing pore blockage, ultimately enhancing the appearance of acne-prone skin. With nearly 90% of the global population affected by some form of acne, the condition poses a widespread challenge. In the United States alone, approximately 12 million individuals struggle with severe acne, which, if untreated, can result in skin scarring. Consequently, a significant portion of the population invests in acne care drugs and products to manage the condition. Hence, the mounting prevalence of acne stands as a substantial driver catalyzing growth within the acne drug market.

The latest trend shaping the acne drug market is the adoption of combination therapy, involving the simultaneous use of two drugs with distinct mechanisms of action. Such combinations exhibit enhanced efficacy and improved adherence compared to monotherapy, which involves using a single drug in isolation. This approach combines a topical retinoid drug, effective in unclogging pores, with an antimicrobial drug utilized for treating infections in acne management. Examples of combination therapy include products such as Epiduo, Acanya, Ziana, and Benzamycin, manufactured by Galderma, Allergan, Medicis, and Atrix, respectively.

Leading companies operating in the acne drug market are actively engaged in developing advanced receptor inhibitor drugs and broadening their research into treatment advancements to gain a competitive edge in the burgeoning healthcare sector. Advanced receptor inhibitor drugs function by blocking the activity of specific receptors within the body. For instance, in September 2023, Sun Pharmaceutical Industries Ltd., an India-based biopharmaceutical company, introduced (PR)WINLEVI (clascoterone cream 1% w/w). WINLEVI is formulated to mitigate the effects of acne hormones on the skin by disrupting the androgen cascade, departing from the topical approach in acne treatment that targets follicular hyperkeratinization, inflammation reduction, or antibacterial properties. While the precise mechanism of action of WINLEVI remains under study, it aims to suppress androgen receptor activities within sebaceous gland cells, thereby reducing sebum (oil) production and inflammatory cytokines associated with acne.

In December 2021, the pharmaceutical and healthcare giant Sanofi S.A., headquartered in France and renowned for its expertise in drug development and commercialization, successfully acquired Origimm Biotechnology GmbH for an undisclosed sum. This strategic move by Sanofi aims to bolster its vaccine research and development (R&D) pipeline, enhance its proficiency in skin microbiome and skin immunology, and broaden its array of treatment options for acne. Furthermore, as a result of this acquisition, Sanofi is poised to extend the reach of these innovative products to encompass the entire European market. Origimm Biotechnology GmbH, based in Austria, is a pioneering pharmaceutical company known for its advancements in identifying pathogenic components of the skin microbiome and bacterial antigens responsible for skin diseases.

Major companies operating in the acne drugs market report are Johnson & Johnson, Galderma S.A., Almirall SA, Bausch Health Companies Inc., GlaxoSmithKline, Reckitt Benckiser Group, Mayne Pharma Group Limited, Allergan Plc., Cipher Pharmaceuticals, Sol Gel Advanced Topical Therapy, Pfizer Inc., Novartis AG, Merck & Co. Inc., Amgen Inc., Abbott, AstraZeneca, Eli Lilly and Company, Daiichi Sankyo Company Limited, Sinopharm Group Co. Ltd., Mylan N.V., F. Hoffmann-La Roche Ltd., Bayer AG, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Allergan, Cipla Inc., Zydus Cadila, Otsuka Pharmaceutical Co. Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Jiangsu Hengrui Medicine, Guangzhou Baiyunshan Pharmaceutical, China Meheco Co Ltd., Huadong Medicine Co. Ltd., Pfizer Inc., Galderma S.A., Amgen Europe B.V., Roche Holding AG, Ranbaxy Laboratories, Stiefel Laboratories, BIOCAD, Zentiva (Sanofi), Gedeon Richter PLC, Polpharma SA Pharmaceutical Works, Egis Group, Dermira Inc., Bausch Health Companies Inc., Estee Lauder Inc., Nimue Skincare International.

North America was the largest region in the acne drugs market in 2023. The Middle East is expected to be the largest growing region in the global acne drugs market during the forecast period. The regions covered in the acne drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acne drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The acne drugs market consists of sales of retinoids, antibiotics, and diapsone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acne Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acne drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acne drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acne drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Inflammatory Acne Drugs; Non-Inflammatory Acne Drugs
• 2) By Therapeutic Class: Retinoids; Antibiotics; Salicylic Acid; Benzoyl Peroxide; Other Therapeutics
• 3) By End User: Hospitals & Clinics; Pharmacies & Drug Stores; Other End Users
• Companies Mentioned: Johnson & Johnson; Galderma S.A.; Almirall SA; Bausch Health Companies Inc.; GlaxoSmithKline
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acne Drugs Market Characteristics

3. Acne Drugs Market Trends And Strategies

4. Acne Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Acne Drugs Market Size and Growth

• 5.1. Global Acne Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Acne Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Acne Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acne Drugs Market Segmentation

• 6.1. Global Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Inflammatory Acne Drugs
• Non-Inflammatory Acne Drugs
• 6.2. Global Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retinoids
• Antibiotics
• Salicylic Acid
• Benzoyl Peroxide
• 6.3. Global Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals & Clinics
• Pharmacies & Drug Stores
• Ambulatory Surgical Centers

7. Acne Drugs Market Regional And Country Analysis

• 7.1. Global Acne Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Acne Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acne Drugs Market

• 8.1. Asia-Pacific Acne Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acne Drugs Market

• 9.1. China Acne Drugs Market Overview
• 9.2. China Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acne Drugs Market

• 10.1. India Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acne Drugs Market

• 11.1. Japan Acne Drugs Market Overview
• 11.2. Japan Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acne Drugs Market

• 12.1. Australia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acne Drugs Market

• 13.1. Indonesia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acne Drugs Market

• 14.1. South Korea Acne Drugs Market Overview
• 14.2. South Korea Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acne Drugs Market

• 15.1. Western Europe Acne Drugs Market Overview
• 15.2. Western Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acne Drugs Market

• 16.1. UK Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acne Drugs Market

• 17.1. Germany Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acne Drugs Market

• 18.1. France Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acne Drugs Market

• 19.1. Italy Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acne Drugs Market

• 20.1. Spain Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acne Drugs Market

• 21.1. Eastern Europe Acne Drugs Market Overview
• 21.2. Eastern Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acne Drugs Market

• 22.1. Russia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acne Drugs Market

• 23.1. North America Acne Drugs Market Overview
• 23.2. North America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acne Drugs Market

• 24.1. USA Acne Drugs Market Overview
• 24.2. USA Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acne Drugs Market

• 25.1. Canada Acne Drugs Market Overview
• 25.2. Canada Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acne Drugs Market

• 26.1. South America Acne Drugs Market Overview
• 26.2. South America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acne Drugs Market

• 27.1. Brazil Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acne Drugs Market

• 28.1. Middle East Acne Drugs Market Overview
• 28.2. Middle East Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acne Drugs Market

• 29.1. Africa Acne Drugs Market Overview
• 29.2. Africa Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acne Drugs Market Competitive Landscape And Company Profiles

• 30.1. Acne Drugs Market Competitive Landscape
• 30.2. Acne Drugs Market Company Profiles
  • 30.2.1. Johnson & Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Galderma S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Almirall SA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bausch Health Companies Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. GlaxoSmithKline
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Acne Drugs Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group
• 31.2. Mayne Pharma Group Limited
• 31.3. Allergan Plc.
• 31.4. Cipher Pharmaceuticals
• 31.5. Sol Gel Advanced Topical Therapy
• 31.6. Pfizer Inc.
• 31.7. Novartis AG
• 31.8. Merck & Co. Inc.
• 31.9. Amgen Inc.
• 31.10. Abbott
• 31.11. AstraZeneca
• 31.12. Eli Lilly and Company
• 31.13. Daiichi Sankyo Company Limited
• 31.14. Sinopharm Group Co. Ltd
• 31.15. Mylan N.V.

32. Global Acne Drugs Market Competitive Benchmarking

33. Global Acne Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acne Drugs Market

35. Acne Drugs Market Future Outlook and Potential Analysis

• 35.1 Acne Drugs Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Acne Drugs Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Acne Drugs Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer